Riskpilot← Back to searchSign inGet full accessIndical Sweden AB
ABDissolvedOrg 5592759616Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20204 employees
Revenue 2022
SEK 16,4M
+96% vs 2021
EBITDA margin
28.6%
+1097% vs 2021
Equity ratio
9.6%
Financial strength
Net profit 2022
SEK 2M
+199% vs 2021
| Revenue | SEK 16,4M | +96% |
| EBITDA | SEK 4,7M | +1097% |
| Net profit | SEK 2M | +199% |
| Total assets | SEK 21,3M | +6% |
| Equity | SEK 2M | +7738% |
| Employees | 4 | — |
Legal name
Indical Sweden AB
Org number
5592759616
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 oktober 2020
Share capital
SEK 25 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Santarelli, Stefano Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva veterinär diagnostik.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 |
|---|---|---|
| Revenue | 8 391 | 16 420 |
| Staff expenses | — | — |
| EBITDA | −472 | 4 704 |
| Depreciation & amort. | −1 262 | −1 800 |
| EBIT | −1 734 | 2 904 |
| Net financials | −289 | −298 |
| Profit before tax | −2 023 | 2 012 |
| Tax | −0 | −0 |
| Net profit | −2 023 | 2 012 |
| Item | 2021 | 2022 |
|---|---|---|
| Total assets | 20 107 | 21 286 |
| Equity | 26 | 2 038 |
| Long-term debt | 11 571 | 13 187 |
| Short-term debt | 8 510 | 5 758 |
| Total debt | 20 081 | 18 945 |
EBITDA margin
28.6%
This company
15.8%
Market median
+81% vs market
20212022
Equity ratio
9.6%
This company
38.2%
Market median
-75% vs market
20212022
Return on equity
98.7%
This company
18.4%
Market median
+436% vs market
20212022
Net profit margin
12.3%
This company
8.1%
Market median
+52% vs market
20212022
Asset turnover
0.77×
This company
1.12×
Market median
-31% vs market
20212022
Debt / equity
9.44×
This company
0.62×
Market median
-1423% vs market
20212022
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SP Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
JO Authorized Recipient of Service | Authorized Recipient of Service | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2021 | |
| Board of Directors | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Deputy Board Member | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Indical TopCo AB
Indical Sweden AB Board members of Indical Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sopana Ponnambalam Leife | Chief Executive Officer | 0 companies |
| Jacob Olof Wiström | Authorized Recipient of Service | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Claudia Cornelia Engemann | Board of Directors | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Carl Fredrik Michael Ullman | Chairman | 0 companies |
| Peter Demarmels | Deputy Board Member | 0 companies |
| Stefano Santarelli | Board of Directors | 0 companies |